These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4895428)
41. [Azathioprine, 6-mercaptopurine, and inflammatory diseases of the intestine]. Beaugerie L; Gendre JP Gastroenterol Clin Biol; 1990; 14(3):230-40. PubMed ID: 2188863 [No Abstract] [Full Text] [Related]
42. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide]. Sun Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067 [No Abstract] [Full Text] [Related]
43. Clinical experience with mitomycin C (NSC-26980). Whittington RM; Close HP Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088 [No Abstract] [Full Text] [Related]
44. Phase II oncology trials: let's be positive. Ratain MJ Clin Cancer Res; 2005 Aug; 11(16):5661-2. PubMed ID: 16115898 [No Abstract] [Full Text] [Related]
45. Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037). DeConti RC; Hubbard SP; Pinch P; Bertino JR Cancer Chemother Rep; 1973 Apr; 57(2):201-7. PubMed ID: 4742499 [No Abstract] [Full Text] [Related]
50. Prospective clinical trial of a human tumor cloning system. Von Hoff DD; Clark GM; Stogdill BJ; Sarosdy MF; O'Brien MT; Casper JT; Mattox DE; Page CP; Cruz AB; Sandbach JF Cancer Res; 1983 Apr; 43(4):1926-31. PubMed ID: 6339044 [TBL] [Abstract][Full Text] [Related]
51. The use of drugs in combination for the treatment of cancer: rationale and results. DeVita VT; Schein PS N Engl J Med; 1973 May; 288(19):998-1006. PubMed ID: 4348752 [No Abstract] [Full Text] [Related]
53. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs]. Bollag W Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076 [No Abstract] [Full Text] [Related]
54. [Results of clinical study of the antineoplastic antibiotic rubomycin]. Akop'iants SS Antibiotiki; 1968 Sep; 13(9):846-50. PubMed ID: 4884477 [No Abstract] [Full Text] [Related]
55. Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms. Stolinsky DC; Hum GJ; Jacobs EM; Solomon J; Bateman JR Cancer Chemother Rep; 1973; 57(4):477-80. PubMed ID: 4586954 [No Abstract] [Full Text] [Related]
57. Personalized-medicine trials on the rise. Benowitz S J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496 [No Abstract] [Full Text] [Related]
58. Role of chemotherapy against micrometastatic cancer. Harstrick A; Klaassen U; Eberhardt W; Seeber S Cancer Metastasis Rev; 1999; 18(1):151-72. PubMed ID: 10505553 [No Abstract] [Full Text] [Related]
59. Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study. Hewlett JS; Bodey GP; Wilson HE; Stuckey WJ Cancer Treat Rep; 1979 Jan; 63(1):156-8. PubMed ID: 369690 [No Abstract] [Full Text] [Related]
60. New approaches in administration of anticancer drugs. Rall DP Cancer Res; 1969 Dec; 29(12):2471-4. PubMed ID: 5369694 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]